News and Events
"A Precision Medicine Approach to Smoking Cessation Among Native Americans"
Dana Mowls Carroll, Ph.D.
Postdoctoral Fellow, Tobacco Research Programs
University of Minnesota
Friday, October 5
2 PM - 3 PM
1-451 Moos Tower (TC); 302 Heller Hall (Duluth via ITV)
Dr. Dana Mowls Carroll is a postdoctoral fellow in the Tobacco Research Programs at the University of Minnesota, led by Masonic Cancer Center member Dr. Dorothy Hatsukami. Her research interests are in tobacco-related disparities, cancer prevention, and tobacco regulatory science. She received a Ph.D. in epidemiology from the University of Oklahoma Health Sciences Center in 2017. She aims to direct an independent research group that contributes to the reduction of tobacco-related morbidity and mortality with a special emphasis on populations that bear the greatest burden—populations that are often understudied and historically underserved. Her presentation will provide an overview of a Minnesota Precision Medicine Collaborative (MPMC) project which seeks to increase access to precision medicine approaches to smoking cessation in the Native American population in Minnesota.
This event is free and open to the public. Light refreshments will be served.
Pamala Jacobson received the Sara Evans Faculty Woman Scholar/ Leader Award from the University of Minnesota Women’s Center, Office for Equity and Diversity and was honored at their Celebrating Changemakers Awards event on October 11, 2018.
This session highlighted the social and cultural challenges associated with providing care to local Native American tribes in Minnesota, who face larger health disparities than other populations. Pamala Jacobson, Professor, Experimental and Clinical Pharmacology, University of Minnesota, Anne Joseph, Wexler Professor of Medicine, Division of General Internal Medicine, University of Minnesota and Kris Rhodes, CEO, American Indian Cancer Foundation joined The Atlantic’s Steve Clemons to talk about why Minnesota is aptly positioned to do this important work in Native American tribes.
Samuel is a PhD Candidate in the Experimental and Clinical Pharmacology department. During his time in the program Samuel has pursued various avenues of research related to precision medicine in neuropharmacology with a focus on anti-seizure drugs.
Welocome to our newest member, Debra Skaar, PharmD, FCCM. She is an Associate Professor in Experimental and Clinical Pharmacology. Read her hio here.
Jay's research focuses on the determination of known genetic variations within Very Important Pharmacogenes (VIPs) in the Hmong population which brings local, state-wide and regional relevance to the nationally supported NIH “Precision Medicine Initiative”.
Robert Straka is a President's Community-Engaged Scholar Award Collegiate Recipient. View a video of his work in the Hmong community.
The 2nd annual Summit on Precision Medicine held on March 22, 2018 on the Duluth campus was a success. This year the focus of the summit was on Precision Medicine in Native American and Rural Health.
See the FOX21 story on how The School of Medicine at the University of Minnesota Duluth is discussing populations with health disparities.
Experts on campus are addressing how native american and rural communities could receive better medical attention.
Cathy McCarty was the Principal Investigator for the Marshfield Clinic Personalized Medicine Research Project, with more than twenty genetic epidemiology and pharmacogenetic studies of metformin, coumadin and ACE inhibitors. She is currently collaborating with Dr.
A College of Pharmacy internal grant has been awarded to the project, "Enhance Comprehensive Pharmacist Services to Improve Patient Health: Creating a 21 st Century Precision Medicine Intensive Care Unit (ICU)."
The focus of the project is on sedation in mechanically ventilated patients and it aims to identify actionable genetic variants in ICU patients and evaluate the relationship between genotypes and drug efficacy as well as adverse drug reactions (ADR) in a real-world setting at the bedside.
Genomic Testing to Individualize Drug Therapy
The 2018 Pharmacogenomics Confernece on June 22 was at capacity with over 310 registrants in attendance. Topics included: cancer somatic mutations and selection of targeted therapies, emerging PGx areas. Read about the event here.